MBD1 Mouse Monoclonal Antibody [Clone ID: 100B272.1]

CAT#: TA336395

Mouse Monoclonal MBD1 Antibody (100B272.1)


USD 424.00

5 Days*

Size
    • 100 ug

Frequently bought together (2)
Transient overexpression lysate of methyl-CpG binding domain protein 1 (MBD1), transcript variant 3
    • 100 ug

USD 396.00


beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

USD 159.00

Other products for "MBD1"

Specifications

Product Data
Clone Name 100B272.1
Applications WB
Recommended Dilution Knockdown Validated, Chromatin Immunoprecipitation (ChIP): 1:10-1:500, Western Blot: 2-4 ug/ml, Chromatin Immunoprecipitation: 1:10-1:500, Immunoprecipitation: 1:10-1:500, Immunohistochemistry-Frozen, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry: 1:200, Immunohistochemistry-Paraffin: 1:200
Reactivities Human
Host Mouse
Isotype IgG1
Clonality Monoclonal
Immunogen This antibody was generated by immunizing mice with a synthetic peptide corresponding to amino acids 391-405 (SESEDGAGSPPPYRR) of human MBD1; GenBank no ref|NP_056671.2|
Formulation PBS containing 0.05% BSA, 0.05% Sodium Azide. Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration lot specific
Purification Protein G purified
Conjugation Unconjugated
Storage Store at -20°C as received.
Stability Stable for 12 months from date of receipt.
Gene Name methyl-CpG binding domain protein 1
Background DNA methylation, or the addition of methyl groups to cytosine bases in the dinucleotide CpG, is imperative to proper development and regulates gene expression. The methylation pattern involves the enzymatic processes of methylation and demethylation. The demethylation enzyme was recently found to be a mammalian protein, which exhibits demethylase activity associated to a methyl-CpG-binding domain (MBD). The enzyme is able to revert methylated cytosine bases to cytosines within the particular dinucleotide sequence mdCpdG by catalyzing the cleaving of the methyl group as methanol. MeCP2 and MBD1 (PCM1) are first found to repress transcription by binding specifically to methylated DNA. MBD2 and MBD4 (also known as MED1) were later found to colocalize with foci of heavily methylated satellite DNA and believed to mediate the biological functions of the methylation signal. Surprisingly, MBD3 does not bind methylated DNA both in vivo and in vitro. MBD1, MBD2, MBD3, and MBD4 are found to be expressed in somatic tissues, but the expression of MBD1 and MBD2 is reduced or absent in embryonic stem cells, which are known to be deficient in MeCP1 activity. MBD4 have homology to bacterial base excision repair DNA N-glycosylases/lyases. In some microsatellite unstable tumors MBD4 is mutated at an exonic polynucleotide tract.
Synonyms CXXC3; PCM1; RFT
Reference Data
Protein Families Druggable Genome, Transcription Factors

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.